Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emricasan in Liver Transplantation
NCT00080236Phase 2Completed
- Sponsor
- Conatus Pharmaceuticals Inc.
- Start
- Nov 2003
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of emricasan in ischemia-reperfusion injury (IRI), sponsored by Conatus Pharmaceuticals Inc.. Started Nov 2003; status: completed.
02
Drugs
emricasan
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00080236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080236.